Lee MMY, Petrie MC, McMurray JJV, Sattar N, et al. How Do SGLT2 (Sodium-Glucose Cotransporter 2) Inhibitors and GLP-1 (Glucagon-Like Peptide-1) Receptor Agonists Reduce Cardiovascular Outcomes?: Completed and Ongoing Mechanistic Trials. Arterioscler Thromb Vasc Biol 2020 Jan 30:ATVBAHA119311904.
PMID: 31996025